Oscient Pharmaceuticals Corporation Records 2007 Revenues of $80 Million; Reports Financial Results for Fourth Quarter and Fiscal Year 2007

February 6, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) today reported financial results for the fourth quarter and fiscal year ended December 31, 2007. Highlights from the year include:

Twitter
LinkedIn
Facebook
Email
Print

Earnings